Page last updated: 2024-11-04

sarpogrelate and Scleroderma, Limited

sarpogrelate has been researched along with Scleroderma, Limited in 1 studies

sarpogrelate: structure given in first source

Scleroderma, Limited: The least progressive form of SYSTEMIC SCLERODERMA with skin thickening restricted to the face, neck and areas distal to the elbows and/or knees, sparing the trunk. The CREST SYNDROME is a form of limited scleroderma.

Research Excerpts

ExcerptRelevanceReference
"Sarpogrelate was considered to be a useful drug to improve skin ulcers and QOL in patients with SSc."5.38Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis. ( Furukawa, F; Ikeda, T; Kanazawa, N; Uede, K; Yoshimasu, T, 2012)
"Sarpogrelate was considered to be a useful drug to improve skin ulcers and QOL in patients with SSc."1.38Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis. ( Furukawa, F; Ikeda, T; Kanazawa, N; Uede, K; Yoshimasu, T, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshimasu, T1
Ikeda, T1
Uede, K1
Kanazawa, N1
Furukawa, F1

Other Studies

1 other study available for sarpogrelate and Scleroderma, Limited

ArticleYear
Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis.
    The Journal of dermatology, 2012, Volume: 39, Issue:6

    Topics: Aged; Female; Humans; Male; Middle Aged; Quality of Life; Scleroderma, Diffuse; Scleroderma, Limited

2012